JONATHAN AVALOS: Open Payments
NPI 1386050805 · RIALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$97 in 4 payments from 4 companies in 2025. Trend: 2023 $94 · 2024 $83 · 2025 $97
Food & beverage: $97
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Alkermes, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: CAPLYTA, VIVITROL, ABILIFY ASIMTUFII, COBENFY.
Industry payments across CA — which companies pay providers there.
